Revolution Medicines Balance Sheet
NASDAQ: RVMDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Revolution Medicines financial position
At the end of fiscal 2025, Revolution Medicines reported total assets of $2.35 billion, down 8.0% from a year earlier against total liabilities of $723.2 million. Shareholders' equity stood at $1.63 billion, or 69.3% of assets. The company held $383.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 7.14, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Revolution Medicines balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 383.75M | 543.06M | 696.15M | 161.41M | 108.50M | 104.27M | 16.66M | 69.59M |
| Short-Term Investments | 1.64B | 1.75B | 1.16B | 483.53M | 468.56M | 336.47M | 106.10M | — |
| Total Current Assets | 2.08B | 2.33B | 1.88B | 660.18M | 589.77M | 454.12M | 133.98M | — |
| Property, Plant & Equipment | 33.19M | 24.29M | 22.86M | 18.66M | 11.54M | 8.90M | 7.15M | — |
| Goodwill | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | — |
| Intangible Assets | 55.80M | 56.67M | 57.74M | 58.81M | 59.88M | 60.95M | 62.01M | — |
| Total Assets | 2.35B | 2.56B | 2.06B | 811.93M | 737.99M | 567.40M | 220.53M | — |
| Accounts Payable | 64.62M | 54.43M | 61.79M | 21.31M | 14.06M | 12.61M | 11.40M | — |
| Total Current Liabilities | 290.42M | 163.91M | 143.85M | 61.98M | 60.35M | 47.18M | 43.05M | — |
| Total Liabilities | 723.21M | 293.10M | 235.51M | 126.74M | 135.42M | 92.72M | 67.99M | — |
| Shareholders' Equity | 1.63B | 2.27B | 1.83B | 685.19M | 602.57M | 474.68M | -152.57M | -108.42M |
| Retained Earnings | -2.87B | -1.74B | -1.14B | -701.34M | -452.64M | -265.55M | -157.39M | — |
| Net Cash (Debt) | 2.03B | 2.29B | 1.85B | 644.94M | 577.05M | 440.74M | 122.76M | 69.59M |
| Shares Outstanding | 197.00M | 185.90M | 164.67M | 90.41M | 74.14M | 66.60M | 3.29M | — |
This table shows 8 annual periods of Revolution Medicines's balance sheet, from FY 2025 back to FY 2018, across 14 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow RVMD's reporting calendar. What is a balance sheet?